A NEW drug to tackle Alzheimer's has been approved in the US amid growing calls for the NHS to improve early diagnosis so Brits can benefit from the treatment.
UK regulators are still considering donanemab but could follow the US Food and Drug Administration which on Tuesday approved what is one of the world's first disease-modifying treatments for dementia.
This story is from the July 04, 2024 edition of Daily Mirror UK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the July 04, 2024 edition of Daily Mirror UK.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Change the system, get creative and the Euros are there to be won
Mr Marmite.. Love him, hate him, you can't ignore him
SERENE WILLIAMS
Alex aims to wake up the sleeping giant that owned this race with Mansell and Hill
A ROVER'S Join #168 RETURN!
Abdull says he has nothing to prove as he faces old pals for first time
Back to The Tribe
TV adventurer Bruce Parry to revisit remote communities for BBC series
Unexpected anger in the bagging area
Tech problems and self-checkout machines take up too much time
Pride of Three Lions
David: Hearing Euro song at game better than being dad
BLADES OF GLORY
Olivia celebrates turning 17 by becoming youngest female helicopter pilot
MISSING JAY FAKE WEB CLIP WARNING
Old vid 'clearly not Tenerife teen'
Bid to oust Maddie suspect trial judge
Brueckner may walk free fear prosecutors
'I'm innocent'
Judge slams killer nurse Lucy Letby over lack of remorse as she is handed 15th whole-life term but continues to deny quilt
